Profile
Research interests
Tim is interested in improving the outcomes for stroke patients through the improvement of currently available thrombolytic drugs. The primary aim is to improve the properties of the thrombolytic staphylokinase towards enhanced thrombolysis with minimal side effects. He aims to address this question through various computational molecular dynamics simulation tools, including adaptive sampling MD simulations and classical MD simulations. Through this, he seeks to introduce rational changes to the protein to improve its properties and applications as a thrombolytic.Education
2023 MSc., Biomedical Science, Faculty of Health, Medicine, and Life Sciences, Maastricht University, Maastricht, Netherlands2023 MSc., Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan
2021 BSc., Biomedical Science, Faculty of Health, Medicine, and Life Sciences, Maastricht University, Maastricht, Netherlands
